per conoscere, per riflettere, per costruire reti

I will never understand why speaking up, criticizing, joining a debate means nowadays that you must get ready to be insulted and smeared. This society is sicker than ever. We should all reclaim the right to have opinions and speak them out without being insulted.

@serenatinari | Serena Tinari | 20.02.2021

L’attuale distribuzione del #vaccino contro il #COVID19 non è solo ingiusta. È anche un grave errore di salute pubblica. Finché non finisce per tutti, nessuno è al sicuro.




@montaldo_chiara | Chiara Montaldo | 19.02.2021

In tempi eccezionali bisognerebbe pensare a modi eccezionali che non lascino la maggior parte delle popolazioni al di fuori delle cure necessarie. L’accesso alle cure non può essere un privilegio.

@AntonioAddis2 | Antonio Addis

I’ve noticed some advocates for a given COVID strategy get annoyed when media don’t cover it as unquestioningly as they’d like. Personally, I think it’s good media ask probing questions of those claiming the ‘best’ COVID solution - after all, they’re journalists, it’s their job.

@AdamJKucharski | Adam Kucharski | 16.02.2021

FYI, not all clinicians are public health experts and not all public health experts are clinicians.

@sdbaral | Stefan Baral | 13.02.2021

The British painter Lucian Freud was a master painter of imperfect people who owned their imperfections.




@NewYorker | The New Yorker | 13.02.2021

Riaperto il tunnel tra il CERN e il Gran Sasso.

@NicolaLagioia | Nicola Lagioia | 12.02.20221

Science by briefing #1001: Rather than quoting a single scientist, how’s about giving us more details about how the studies were done etc etc? It’ll help us science journo types respond to our editors when it lands in our in tray tomorrow

@Deb_Cohen | Deborah Cohen | 11.02.2021

[From the vault] Mapping information exposure on social media to explain differences in HPV vaccine coverage. Coverage was lower where safety concerns, misinformation, and conspiracies made up higher proportions of Twitter exposures. Led by @adamgdunn




@EnricoCoiera | Enrico Coiera | 9.02.2021

Durante i picchi pandemici, a 72h da esordio sintomi è già tanto se c’è esito tampone. Un farmaco ev, da 10mila euro, usato entro 72h per ridurre di poco le ospedalizzazioni in soggetti a rischio mi lascia perplesso. Saremo sommersi di richieste di chiarimento dai familiari...

@marco_vergano | Marco vergano | 6.02.2021

L’Italia investe circa l’1,4% del PIL in ricerca, di cui circa il 20% in ricerca medica. Sono circa 2 miliardi l’anno e sono molto pochi a paragone con le economie più sviluppate. 500 milioni di euro sono circa il 25% di questo budget. Ha senso spenderli sui monoclonali ora?

@DrMCecconi | Maurizio Cecconi | 6.02.2021

Giorgio Palù, presidente Aifa, dice che gli anticorpi monoclonali, efficaci per COVID, vanno fatti solo in chi è nelle fasi iniziali. Considerato che sono farmaci da fare in ospedale, sotto controllo, dove mettiamo queste persone (che sono pure molte di più dei soggetti gravi)?

@MedBunker | Salvo Di grazia | 3.02.2021

Corruption in healthcare. We need a system based on solidarity not greed. One in which patients and clinicians hold the system accountable and responsible for supporting care not the other way around. This is #WhyWeRevolt

@patientrev

@vmontori | Victor Montori | 3.02.2021

Those I consider to be real ‘experts’ don’t tend to:

- claim to be experts

- rely on credentials (real or fake)

- push conspiracies

- monetise their views

- politicise everything

- never express doubt

- try to instil fear

- be always predictable

- take themselves too seriously

@BallouxFrancois | Francois Balloux | 2.02.2021

How nutrition news can lose public’s trust. Here’s a headline on mushrooms, written by a reporter from a press release put out by the Mushroom Council, from a study funded by the Mushroom Council. None of that disclosed in the piece by

@ConsumerAffairs.

@bigfatsurprise | Nina Teicholz | 1.02.2021